Roxana-Adriana Stoica
Overview
Explore the profile of Roxana-Adriana Stoica including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
16
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Salmen T, Potcovaru C, Bica I, Giglio R, Patti A, Stoica R, et al.
Pharmaceuticals (Basel)
. 2024 Oct;
17(10).
PMID: 39458963
This systematic review is registered with CRD42024507397 protocol number and aims to compare the known data about retatrutide on long-term cardiovascular (CV) protection with tirzepatide, an incretin with recent proven...
2.
Reurean-Pintilei D, Pantea Stoian A, Salmen T, Stoica R, Mititelu-Tartau L, Lazar S, et al.
Biomedicines
. 2024 Apr;
12(4).
PMID: 38672244
Advanced Glycation End Products (AGEs) contribute to the pathophysiology of type 2 diabetes mellitus (T2DM) and cardiovascular (CV) diseases (CVDs), making their non-invasive assessment through skin autofluorescence (SAF) increasingly important....
3.
Reurean-Pintilei D, Pantea Stoian A, Potcovaru C, Salmen T, Cinteza D, Stoica R, et al.
Int J Mol Sci
. 2024 Apr;
25(7).
PMID: 38612699
Diabetes mellitus (DM), due to its long-term hyperglycemia, leads to the accumulation of advanced glycation end-products (AGEs), especially in the vessel walls. Skin autofluorescence (SAF) is a non-invasive tool that...
4.
Salmen T, Rizvi A, Rizzo M, Pietrosel V, Bica I, Diaconu C, et al.
Biomedicines
. 2023 Sep;
11(9).
PMID: 37760896
In this paper, we aim to evaluate the efficacy of antidiabetic cardioprotective molecules such as Sodium-Glucose Cotransporter-2 Inhibitors (SGLT-2i) and Glucagon-like Peptide 1 Receptor Agonists (GLP-1 RAs) when used with...
5.
Salmen B, Pietrosel V, Durdu C, Salmen T, Diaconu C, Bica I, et al.
Biomedicines
. 2023 May;
11(5).
PMID: 37239163
The increasing prevalence of gestational diabetes mellitus (GDM) requires non-invasive and precise techniques for evaluating the predisposing risk factors such as visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT)....
6.
Bica I, Pietrosel V, Salmen T, Diaconu C, Braticevici C, Stoica R, et al.
Int J Mol Sci
. 2023 Apr;
24(8).
PMID: 37108347
As the pathophysiologic mechanisms of type 2 diabetes mellitus (T2DM) are discovered, there is a switch from glucocentric to a more comprehensive, patient-centered management. The holistic approach considers the interlink...